We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXDX
3776
DELISTED
Accelerate Diagnostics
AXDX
$942 ﹤0.01%
164
VRN
3777
DELISTED
Veren
VRN
$913 ﹤0.01%
110
NXTC icon
3778
NextCure
NXTC
$26.7M
$906 ﹤0.01%
59
SOHO
3779
DELISTED
Sotherly Hotels
SOHO
$895 ﹤0.01%
533
API
3780
Agora
API
$377M
$885 ﹤0.01%
+350
New +$1K
LITS
3781
Lite Strategy Inc
LITS
$30.9M
$855 ﹤0.01%
122
NEUE
3782
DELISTED
NeueHealth
NEUE
$852 ﹤0.01%
143
-446
-76% -$4.58K
TCRT icon
3783
Alaunos Therapeutics
TCRT
$4.86M
$840 ﹤0.01%
42
WGS icon
3784
GeneDx Holdings
WGS
$2.3B
$815 ﹤0.01%
224
-419
-65% -$2.3K
SCOR icon
3785
Comscore
SCOR
$109M
$806 ﹤0.01%
66
ASTR
3786
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$806 ﹤0.01%
436
-893
-67% -$3.88K
EMKR
3787
DELISTED
Emcore Corp
EMKR
$798 ﹤0.01%
168
GFL icon
3788
GFL Environmental
GFL
$14.9B
$794 ﹤0.01%
25
LTRN icon
3789
Lantern Pharma
LTRN
$36.5M
$777 ﹤0.01%
228
STG
3790
Sunlands Technology
STG
$45.5M
$737 ﹤0.01%
135
VET icon
3791
Vermilion Energy
VET
$1.66B
$731 ﹤0.01%
50
BFRA
3792
DELISTED
Biofrontera AG American Depositary Shares
BFRA
$714 ﹤0.01%
288
EIGR
3793
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$707 ﹤0.01%
77
-86
-53% -$1.73K
RANI icon
3794
Rani Therapeutics
RANI
$89M
$678 ﹤0.01%
312
BPTS
3795
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$657 ﹤0.01%
+13
New +$859
STN icon
3796
Stantec
STN
$8.39B
$648 ﹤0.01%
+10
New +$665
TFII icon
3797
TFI International
TFII
$11.5B
$642 ﹤0.01%
+5
New +$635
PPBT
3798
Purple Biotech
PPBT
$2.33M
$638 ﹤0.01%
3
OMIC
3799
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$633 ﹤0.01%
55
-177
-76% -$3.29K
WKEY
3800
WISeKey
WKEY
$74M
$624 ﹤0.01%
338
+90
+36% +$297

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.